Amiodarone is a benzofuran derivative, which has been used since the beginning of the 1980s as a potent drug to treat patients with refractory cardiac arrhythmias.' It has been associated with adverse reactions affecting the eyes, lung, skin, thyroid, and nervous system.' We report a case of epididymitis associated with amiodarone treatment, which was observed in our clinic for venereal diseases. The patient was treated with erythromycin 2 g a day for 14 days, but without effect. As the pain and swelling worsened, he was admitted to hospital and treated with tetracycline hydrochloride 2g for an additional 10 days and with various analgesics, including drugs of the morphine group. Despite treatment with antibiotics, his condition deteriorated. Treatment with amiodarone was stopped in favour of another antiarrhythmic agent. The swelling and pain subsided during the subsequent week. After six weeks only a slight painless persisting infiltration was found. When the treatment with amiodarone was discontinued the serum concentrations ofamiodarone and its metabolite, desethyl amiodarone,2 were 2.8 mg/l and 2.2 mg/l, respectively, and the concentrations in the hydrocele liquid were 11 mg/l and 0.9 mg/l, respectively. A specimen of semen was not obtainable.
The patient's wife was also examined; no signs of gonorrhoea or chlamydial infection were found.
Discussion
Epididymitis in men under 35 is most often caused by C trachomatis or N gonorrhoeae. In men over 35 the usual infectious agents are coliform bacteria or Pseudomonas aeruginosa. Epididymitis occurs in rare cases of systemic tuberculosis and after the haematogenous spread of numerous other micro-organisms. 3 Our patient showed no signs of infection or anatomical abnormalities and did not respond to prolonged treatment with antibiotics. As the pain and swelling subsided after amiodarone treatment was discontinued, amiodarone was the probable cause of the epididymitis.
258
Amiodarone associated epididymitis has been described previously.'245 Gasparich et al reviewed the records of 56 men treated with amiodarone for refractory ventricular tachycardia and found that six had histories of scrotal pain associated with epididymal enlargement. Only one of them responded to conventional antibiotic treatment, and he was the only patient with unilateral epididymitis. The mean amiodarone dose in the six patients with epididymitis was 700 mg a day, and the duration of treatment before the onset of symptoms was 7-15 months. A significant association was found between the development of epididymitis and high dose amiodarone treatment for a long time.4`This accords with the findings in our patient, who had been treated with 600-800 mg a day for 15 months.
Amiodarone accumulates in the testes and may cause a brown discolouration of semen. Adams et al measured the concentrations of amiodarone and its desethyl metabolite in necropsy samples from five patients who had received amiodarone treatment and found very high concentrations in the testes-among the highest concentrations noted in any tissue. 6 Ibsen, Frandsen, Brandrup, Moller Our findings point to the importance ofconsidering this adverse effect of amiodarone treatment as an aetiological factor in epididymitis. If no bacterial or anatomical cause can be shown discontinuation of treatment or reduction of the dose should be considered in co-operation with the cardiologist.
with amiodarone. 
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